Saline has similar effect to albumin in critically ill patientsBMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7444.852-a (Published 08 April 2004) Cite this as: BMJ 2004;328:852
- Susan Mayor
No difference exists in 28 day mortality between patients who are resuscitated with albumin and those given saline. This is the finding of a large randomised trial of fluid resuscitation in critically ill patients, reported at a recent meeting in the United States.
Results from the saline versus albumin fluid evaluation (SAFE) trial of nearly 7000 critically ill patients showed that 28 day mortality for patients randomised to albumin was 20.9%, whereas mortality in the saline arm was 21.1%. Data were available for a total of 3473 patients receiving albumin and 3460 receiving saline; the mean age of patients was 58 years. Although …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial